It provides a unique opportunity to prospectively and longitudinally investigate the roles of the PNPLA3 I148M variant, obesity, and alcohol intake in the risk of cirrhosis, HCC, and liver disease–related mortality. This evidence concerns the gene PNPLA3 and obesity disorder.